AlamarBio

🧬 Day 3 at AD/PD 2026 and the energy continues. Don't forget to check out the 26+ posters and 11+ sessions, including a featured poster from CTO Xiao Jun Ma highlighting our new Neuro 220 Panel. Visit Booth 15 to see how precision proteomics is advancing AD and PD research.

🔬 AD/PD Day 2 and the discussions keep getting better. NULISA™ technologies are showing strong presence across posters and sessions, with the newly launched NULISAseq™ Neuro 220 Panel expanding AD & PD research. Visit Booth 15 to explore the latest in Precision Proteomics.

📢 Don’t miss our featured poster at #ADPD2026! See Xiao-Jun Ma tomorrow + Saturday (Session 2, Board #355) on an ultra-sensitive, high-multiplex panel for CNS biomarkers from plasma & CSF. Stop by Booth 15 to explore NULISA™ and the latest in Precision Proteomics.

🚨 AD/PD 2026 is off to an incredible start. A standing-room-only session with Henrik Zetterberg unveiled new Neuro 220 data—driving major momentum for Precision Proteomics in AD & PD. Studying PD? Visit Booth 15 to learn more about our grant program and NULISA technologies.

Working on a Parkinson’s disease research project? Apply by April 30, 2026 for Alamar’s Parkinson’s Disease Grant Program—3 awards available, including analysis of 86 samples using the new NULISAseq™ Neuro 220 Panel. 👉 Apply now: na2.hubs.ly/H04mg_R0

Meet the NULISAseq™ Neuro 220 Panel—our most comprehensive neurodegeneration panel yet. Discover how expanded biomarker depth is unlocking new insights across AD, PD, and related CNS diseases. 👉 Learn more: ow.ly/KtM350Yvszy 🔗Read the release: ow.ly/GuCq50Yvszx

🚨 Precision proteomics meets neurodegeneration at #ADPD2026 Join tomorrow’s Product Theater with Henrik Zetterberg (GU) on high-sensitivity, multiplex protein profiling from biofluids with NULISA—unlocking deeper insights into Alzheimer's and neurodegenerative disease biology.

🔬 The Alamar Precision Proteomics Summit is coming to St. Louis. Join researchers from Washington University School of Medicine, UBC, and Banner Health for a discussion on neurodegenerative biomarker advances with #NULISA. 👉 Register now: ow.ly/HRLi50Yt4E2

Heading to AD/PD next week? Check out our featured poster #1833 from Dr. Xiao-Jun Ma on an ultra-sensitive multiplex panel for neurological biomarkers. Plus 25+ posters & 11+ sessions powered by NULISA™. 👉 Learn more: ow.ly/QiOV50Yt3PZ

See how precision proteomics is advancing immune regulation research at WIRM 2026! Scientists from around the world are gathering to share the latest discoveries shaping immune regulation and the future of immunology. 👉 Learn more: bit.ly/4u9c97Z

Join our upcoming Labroots webinar hosted by Alex Forrest-Hay, introducing Dr. Carlos Cruchaga as he explores how co-pathologies are reshaping our understanding of AD and why measuring protein signatures is critical for next-gen biomarker research. 🔗: bit.ly/4ugMryL

Explore our featured poster at #ADPD2026 led by Dr. Xiao-Jun Ma on an ultra-sensitive multiplex panel detecting neurological biomarkers from plasma & CSF. Plus, explore 25+ posters & 11+ sessions using #NULISA. 👉 Learn more: bit.ly/4rIz4pc

Join Dr. Henrik Zetterberg (GU) at AD/PD '26 for a Product Theater exploring new precision proteomic data across AD and related diseases and how NULISA and the new NULISAqpcr™ AD 5-Plex Assay are enabling deeper CNS insights from biofluids. Learn more: ow.ly/rHC550YkOVH

We're heading to Manchester! 🔬 Stop by booth 9 to see how ultra-sensitive proteomics is powering next-generation biomarker discovery in Alzheimer’s and dementia — and connect with our team on the challenges shaping the field today. 👉 Learn more: ow.ly/Z5jz50YiZJN

Join Drs. Cara Haymaker, Hussein Abbas, Adam Grippin (MD Anderson), and Doug Hinerfeld (Alamar) as they present #NULISA generated data enabling ultra-sensitive, high-multiplex protein detection from blood across #CNS and #oncology research. Register now: bit.ly/40jiShV

Join us at #ADPD2026 (Booth 15) to learn what’s new in neurodegenerative precision proteomics. See how ultra-sensitive, multiplex profiling with #NULISA & our new AD-5 Plex panel delivers deeper insight into CNS and neuroinflammation. 👉 Learn more: ow.ly/fW3g50YhWyE

We’re heading to US HUPO 2026 🚀 See the fully automated #ARGOHT System live at Booth 26, then join our Feb 25 Breakfast Seminar with Dr. Keenan Walker (NIH) on emerging plasma proteomics data for earlier, more precise Alzheimer’s detection. Learn more: ow.ly/yb0A50YczTB

We're proud to be a Bronze Sponsor of the Alzheimer’s Research UK Conference 2026. Visit us at booth 9 to learn how ultra-sensitive proteomics is advancing Alzheimer’s & dementia biomarker research. 👉 Learn more: alamarbio.com/event/aruk2026/ #ARUKCONF #Proteomics #Biomarkers

We’re kicking off Day 1 at the 14th APDD Summit as a Lead Partner! Join us tomorrow for a presentation by Dr. Chris Bunker on how #NULISA enhances blood-based Alzheimer’s detection and scalable CNS biomarker analysis. 🕤 9:30–10 AM |📍 Booth 3 👉Details: bit.ly/3NXlK18

Last chance to register for tomorrow’s webinar with Dr. Niyati Jhaveri of Alamar Biosciences on how #NULISA and the #ARGOHT System enable high-plex protein detection from minimally invasive samples for #neuroscience and #immunology. 🔗 Register now: ow.ly/VfHA50Y7ZFB